Form D · Pharmaceuticals
Tango Therapeutics, Inc.
Boston, MA · CIK 0001819133
Offering snapshot reported Oct 28, 2025 · SEC filing
- Reported sold
- $15M Offering amount: $15M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 24, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 28, 2025 | Initial | $14,999,995 | No comparison | 1 | SEC filing |
| Aug 24, 2023 | Initial | $80,016,604 | No comparison | 17 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-562231
Source: Form D, filed Oct 28, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Douglas Barry | Executive |
| Daniella Beckman | Executive |
| Alexis Borisy | Director |
| Lesley Ann Calhoun | Director |
| Adam Crystal | Executive |
| Aaron Davis | Director |
| Alan Huang | Executive |
| Reid Huber | Director |
| John Ketchum | Director |
| Malte Peters | Director |
| Kanishka Pothula | Director |
| Mace Rothenberg | Director |
| Barbara Weber | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
201 Brookline Avenue Suite 901
Boston, MA, 02215
Phone: (857) 320-4900
Boston, MA, 02215
Phone: (857) 320-4900